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Abstract
Objectives: There is a lack of independent longitudinal evidence on the factor
structure and validity of the Zanarini Rating Scale for Borderline Personality Dis-
order (ZAN‐BPD). This study aimed to investigate the dimensionality of ZAN‐BPD
and its conceptual consistency over time.
Methods: Adult BPD participants (n = 276) were recruited for a multicentre, two‐
arm randomised clinical trial with ZAN‐BPD measured at baseline and follow up at
12, 24 and 52 weeks. The construct and stability of the ZAN‐BPD across 52 weeks
was examined through a measurement equivalence/invariance procedure via
Exploratory Structural Equation Modelling.
Results: Factor analysis results showed that the ZAN‐BPD had a bi‐2 factor
structure that was stable over 52 weeks with a general factor and two specific
factors. Factor loadings for eight of the nine items were greater for the general
factor than the two specific factors. Factor 1 contrasts externalising distress with
internalising distress. Factor 2 contrasts depression and self‐destruction with
interpersonal anxiety and conflict.
Conclusion: ZAN‐BPD is a conceptually and empirically valid measure of total BPD
symptom severity in BPD patients over time suitable for use in clinical trials. Two
factors related to the expression of distress and self‐harm may be utilised as
possible predictors of outcome.
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1 | INTRODUCTION
Borderline personality disorder (BPD) is a serious psychiatric disor-
der, characterized by domains of affective disturbance, disturbed
cognition, impulsivity and intense unstable relationships (Lieb
et al., 2004). The Zanarini Rating Scale for Borderline Personality
Disorder (ZAN‐BPD) was developed as an outcome measure for
intervention research. It demonstrates good psychometric charac-
teristics such as high levels of reliability, strong convergent validity
with other measures, and sensitivity to detecting change in the
severity of the symptoms of BPD (Zanarini, 2003; Zanarini
et al., 2015). Hence, ZAN‐BPD has become widely used as a BPD
specific outcome measure in recently conducted randomized clinical
trials (RCTs; Black et al., 2014; Blum et al., 2008; Crawford
et al., 2018; Hasler et al., 2014). However, there are no studies
conducted independently of the designers of the measure that
explore the factor structure of the ZAN‐BPD scale longitudinally
over time in clinical samples of BPD patients.
Furthermore, there is a problem with construct validity affecting
all BPD outcome measures based on DSM‐IV or V diagnostic criteria
for BPD, including the ZAN‐BPD. None of them show consistent
construct validity across studies, with the numbers of dimensions
ranging from one to four (Becker et al., 2010; Clarkin et al., 1993;
Clifton & Pilkonis, 2007; Leung & Leung, 2009; Sanislow, Morey,
et al., 2002; Sanislow et al., 2000; Speranza et al., 2012). The nine‐
item ZAN‐BPD was originally designed to evaluate affective, cogni-
tive, impulsive and interpersonal symptoms, which are the four core
areas of BPD psychopathology (Zanarini, 2003; Zanarini et al., 2015).
However, the four‐factor structure was only reported cross‐
sectionally in a study of a normal adolescent population screened
with the MacLean Screening Instrument for BPD (Leung &
Leung, 2009). In a clinical sample of adult BPD patients, the designers
of the ZAN‐BPD found that the measure fitted a two‐factor model
rather than the posited four‐factor structure, and the two‐factor
structure was stable over two time points in a clinical sample
(Zanarini et al., 2015).
There is a need to independently test the factor structure of the
ZAN‐BPD in a large clinical sample of BPD patients measured
longitudinally across more than two time points. An outcome mea-
sure suitable for intervention research as a primary outcome variable
must show empirically that the meaning of questionnaire items and
factor structure are both conceptually valid and stable across
repeated measurement over time. Otherwise interventions might
appear to be effective when they are not because change might be
due to the unstable questionnaire construct over time. Using factor
analysis, measurement equivalence or invariance (ME/I) indicates
that the same constructs are being measured over time (Vanden-
berg & Lance, 2000).
To explore the dimensionality of the ZAN‐BPD as a measure,
both exploratory factor analysis (EFA) and confirmatory factor
analysis (CFA) have previously been used (Becker, Añez, et al., 2010;
Becker et al., 2006; Johansen et al., 2004; Leung & Leung, 2009;
Sanislow, Grilo, & McGlashan, 2000). However, recent methodology
showed that both EFA and CFA have methodological limitations
(Asparouhov & Muthén, 2009; Marsh, Morin, et al., 2014). EFA
modelling cannot incorporate latent EFA factors into subsequent
analyses. Moreover, it is difficult to test measure invariance across
groups and/or times (Marsh, Morin, et al., 2014). When using CFA
modelling, each item is strictly loaded on only one factor and all non‐
target loadings are constrained to zero. The latest analytical
approach, Exploratory Structural Equation Modelling (ESEM), in-
tegrates the best features of both EFA and CFA together. It applies
EFA rigorously to specify more appropriately the underlying factor
structure together with the advanced statistical methods typically
associated with CFAs (Marsh, Morin, et al., 2014). ESEM allows cross
item factor loadings that are coherent with the underlying theory
and/or item contents so that items may cross load on different latent
factors. ESEM reduces the bias in parameter estimates due to zero
loading restriction that generally results in inflated CFA factor cor-
relations. The latter might occur if items are not perfect factor in-
dicators with some degree of irrelevant association with other
constructs (Guay et al., 2015; Marsh, Morin, et al., 2014; Morin,
Arens, & Marsh, 2016). Therefore, we used ESEM to explore the
dimensionality of ZAN‐BPD in this study.
Using ZAN‐BPD item total scores to reflect the severity of BPD
implies that there is one overarching general BPD factor on this
measure (Zanarini, 2003; Zanarini et al., 2015). Bi‐factor models have
statistical advantages over the traditional second order factor
analytical model (Chen et al., 2006; Morin, Arens, & Marsh, 2016;
Morin, Arens, Tran, & Caci, 2016). In bi‐factor models all items are
simultaneously loaded on the overarching global factor with specific
factors representing each of the a priori sub‐factors of the measure.
We will explore if the ZAN‐BPD has an overarching general factor by
means of bi‐factor modelling.
In summary, ESEM was performed to explore the construct
validity of the ZAN‐BPD over time for BPD patients. The conceptual
consistency of the ZAN‐BPD was examined by means of the ME/I
procedure.
2 | METHOD
2.1 | Samples and ZAN‐BPD
Participants were 276 BPD patients (mean [sd] age = 36.1 [11] years,
208 [75.6%] female, 246 [89.13%] white, 200 [72.46%] unemployed).
They were drawn from a multicentre, double‐blinded, two‐arm RCT
comparing lamotrigine treatment effects over placebo with the ZAN‐
BPD as the primary outcome measure (Crawford et al., 2018). Each
participant met DSM‐IV criteria for borderline personality disorder,
as assessed by the Structured Clinical Interview for DSM‐IV Axis II
Personality Disorders (First et al., 1997). Further patient de-
mographic and clinical information may be found in the trial report
(Crawford et al., 2018). Patients' outcomes were evaluated at base-
line and follow up at 12, 24 and 52 weeks after the randomization.
Three participants withdrew shortly after randomisation and did not
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complete their baseline assessments so only 273 patients' data were
included in the analysis.
The severity of BPD was evaluated by clinicians using the
interview version of the ZAN‐BPD which has the following nine items
for the four categories of BPD symptoms: affective symptoms
(chronic angry/frequent angry acts; affective instability; chronic
emptiness); cognitive symptoms (stress‐related paranoia/dissocia-
tion; serious identity disturbance); impulsivity symptoms (self‐
destructive efforts; other impulsivity) and interpersonal symptoms
(frantic efforts to avoid abandonment; stormy relationships). Each
item was rated in order of severity with 0 = no, 1 = mild, 2 = mod-
erate, 3 = serious and 4 = severe symptoms. The item total score,
ranging from 0 to 36, indicated the level of symptoms and behav-
ioural problems experienced by BPD patients. Comparisons of the
ZAN‐BPD total score were made between arms at each follow up in
the trial. At week 52 the mean (SD) totals were 11.3 (6.6) and 11.5
(7.7) for treatment arm and control arm respectively. There were no
statistically significant differences between the two treatment arms
on the ZAN‐BPD nor on any secondary outcome measure in this trial.
2.2 | Statistics
The factor structure of the ZAN‐BPD was explored using ESEM
(Marsh, Morin, et al., 2014). CFA was firstly conducted to replicate
the posited ZAN‐BPD factor structure but failed (Supplementary
Appendix A). We tested separately one to five first order factors and
also bi‐factor models with one to four domain specific factors for
data measured at each follow up time point. All aforementioned
factor structures were further tested using all data measured at each
time point stored in a wide format. Alike items factor loading pa-
rameters were set equal and unequal across all measurement time
points. Ordinal item scores were analysed with the diagonally
weighted least squares estimator using Delta parameterization and
oblique rotation. Missing values were automatically accounted for
using the full‐information maximum likelihood approach built into
Mplus (Enders & Bandalos, 2001; Graham, 2003). Measurement
invariance across all the follow‐up time points for the best fitted
factor structure was tested using ESEM by sequentially testing the
configural invariance model and scalar invariance model fittings
(Fried et al., 2016; Muthén & Muthén, 2017; Vandenberg &
Lance, 2000). The metric model is not allowed for ordinal items when
ESEM is used (Muthén & Muthén, 2017). The configural invariance
model tests whether the factor structure was the same on each
occasion, meaning that the pattern of factor loadings on the in-
dicators was the same across measurement waves. The scalar
invariance model further set equal factor loadings for like items and
equal threshold value of like items' regression on the latent variable
(s) across measurement time points. All ESEM models were per-
formed using software Mplus 8 (Muthén & Muthén, 2017).
Due to the sensitivity of the chi‐square (χ2) test to large sample
sizes and non‐normal data (Wen et al., 2004), the criteria for justi-
fying good model fitting in this study are: both comparative fit index
(CFI) and the non‐normed fit index (NNFI) > 0.95, Root Mean Square
Error of Approximation (RMSEA) < 0.05 (Kline, 2015). Since the
statistical data can only examine model fit and not the clinical rele-
vance of factors, the factor loading estimates and item‐factor map-
ping pattern were additionally examined by two experienced
psychiatrists (RM, MC). Model comparisons were generally evaluated
by reference to the χ2 change test using the Mplus DIFFTEST func-
tion to conduct χ2 difference tests, as the WLSMV estimator was
used to analyse ordinal items scores (Muthén & Muthén, 2017). The
χ2 change tests are influenced by sample size and data non‐normality
(Cheung & Rensvold, 2002; Marsh, Muthén, et al., 2009; Vanden-
berg & Lance, 2000). Therefore the CFI change (drop ≥ 0.01) was
used to compare model improvement, because CFI change is inde-
pendent of both model complexity and sample size nor correlated
with the overall fit measurements (Cheung & Rensvold, 2002; Van-
denberg & Lance, 2000).
The data presented here is a secondary data analysis of data
from a RCT (Crawford et al., 2018) that was powered to detect a
minimum clinically important difference between the drug lamo-
trigine and placebo. We utilised all the data available from this RCT
rather than carrying out a formal power calculation for the purposes
of exploring the construct validity of the ZAN‐BPD over time.
3 | RESULTS
3.1 | Factor structure of ZAN‐BPD
When evaluating results of models with various latent factors in this
study, we examined both the loading pattern consistency across
models and mode fitting information for each model. The results of
loading pattern and fitting comparison were summarised and pre-
sented in Supplementary table A2‐2 in appendix B. As to model fit-
tings, the four‐factor and bi‐3 factor solutions did not converge at
baseline so they were excluded from further consideration. The two‐
factor and bi‐1 factor solutions had a RMSEA >0.05 at all four time
points, a CFI <0.95 in both overall model and a NNFI <0.90 on the
overall configural MI model. In contrast both the three‐factor and bi‐
2 models had a much better fit to the data meeting all preset criteria
at all time points and in both overall models except a CFI of 0.946 in
the overall configural model just below the requirement for a CFI
>0.95. This latter requirement was met in the overall loading MI
model with a CFI of 0.962.
Examination of the items of the ZAN‐BPD across time for the 3‐
factor and the bi‐2 factor solutions revealed that the bi‐2 factor so-
lution had a much more stable structure across all time points and in
the overall models. The bi‐2 factor seemed clinically meaningful.
Clinically patients with BPD sometimes differ with respect to whether
they externalise or internalise their distress (Factor 1). Some BPD
patients display a lot of self‐harm associated with emptiness or low
mood while others find it difficult to cope with interpersonal re-
lationships and rarely self‐harm. Therefore, the bi‐2 factor structure is
the best fitted and meaningful model. The model fitting information of
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the bi‐2 factor structure is presented in Table 1; all items loading es-
timates from the model with alike item loading estimates set equal
across measurement times are presented in Table 2. All other ESEM
modelling results are presented in Supplementary Appendix B.
Table 2 shows there is evidence for a general BPD factor on the
ZAN‐BPD and all items statistical significantly load on to this general
factor. Furthermore, eight of the nine ZAN‐BPD items load more
strongly on the general factor than Factors 1 and 2 (Figure 1). Factor
1 may be interpreted as a factor contrasting externalising distress
through anger (chronic anger/frequent angry acts, other impulsivity)
with internalising distress (chronic emptiness, stress‐related para-
noia/dissociation and serious identity disturbance). Factor 2 may be
interpreted as a factor contrasting depression and self‐destruction
(chronic emptiness, self‐destructive acts) with interpersonal anxiety
and conflict (frantic efforts to avoid abandonment, stormy relation-
ships, stress‐related paranoia and dissociation).
3.2 | The construct consistency across time
The modelling fittings of the ME/I test across measurement time are
presented in Table 3. The configural invariance model (a) with default
setting did not fit the data very well if strict criteria (0.90 < both CFI
and NNFI <0.95) are applied. However, the modelling fitting was
improved (Configural [b]) by correlating item 7 repeatedly measured
at each time, which was guided by examining the modification index
information in the configural (a) model (Vandenberg & Lance, 2000).
The threshold invariance model (a) did not fit the data well (both CFI
and NNFI <0.8) by its default setting. After checking the configural
(b) model parameter estimates, 25 (17%) out of 144 threshold pa-
rameters were freely estimated and the model (threshold (b) fitting
improved a lot when it was compared with the threshold (a) model.
The CFI drop from the configural (b) to the threshold (b) model is
ΔCFI = 0.010 so an invariant threshold model was retained. Never-
theless, the threshold (b) model is an acceptable and justifiable partial
invariant threshold model (Vandenberg & Lance, 2000). Therefore,
the ME/I test results showed that the bi‐2 factor structure is
conceptually stable across measurement time points.
T A B L E 1 Model fitting information
of bi‐2 factor structure for all analytical
datasets
Data χ2 (df), p = RMSEA CFI NNFI N
Baseline 12.202 (12), 0.4296 0.008 1.000 0.999 273
12 weeks 13.192 (12), 0.3552 0.021 0.9999 0.996 215
24 weeks 11.432 (12), 0.4923 0.000 1.000 1.002 196
52 weeks 10.405 (12), 0.5805 0.000 1.000 1.005 195
All data unconstrained 653.026 (480), 0.0001 0.036 0.946 0.930 273
All data fully constrained 656.694 (534), 0.0002 0.029 0.962 0.955 273
T A B L E 2 Item factor loadings for Zanarini Rating Scale for Borderline Personality Disorder (bi‐2 factor model for overall data)
Item G Factor Factor 1 Factor 2
Chronic anger/frequent angry acts 0.556 (p < 0.001) −0.329 (p < 0.001) 0.009 (p = 0.742)
Affective instability 0.614 (p < 0.001) −0.012 (p = 0.828) 0.019 (p = 0.584)
Chronic emptiness 0.393 (p < 0.001) 0.286 (p < 0.001) −0.238 (p < 0.001)
Stress‐related paranoia/dissociation 0.588 (p < 0.001) 0.289 (p < 0.001) 0.093 (p = 0.039)
Serious identity disturbance 0.596 (p < 0.001) 0.355 (p < 0.001) −0.019 (p = 0.219)
Frantic efforts to avoid abandonment 0.576 (p < 0.001) 0.027 (p = 0.378) 0.259 (p < 0.001)
Self‐destructive efforts 0.269 (p < 0.001) −0.012 (p = 0.089) −0.388 (p < 0.001)
Other impulsivity 0.563 (p < 0.001) −0.482 (p < 0.001) −0.010 (p = 0.549)
Stormy relationships 0.670 (p < 0.001) −0.092 (p = 0.250) 0.296 (p < 0.001)
F I G U R E 1 The schematic plot of bi‐2 factor model with
significant item loadings as shown in Table 2
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4 | DISCUSSION
In this study, the originally posited four factors of the ZAN‐BPD
(Zanarini, 2003) were not replicated in a British BPD patient group.
The results showed that a bi‐2 factor was the best fitting model at all
time points. The item loading was stable over time and was clinically
valid. The model was also conceptually stable across four measure-
ment time points over 52 weeks. There is a general factor on which
all nine items of the ZAN‐BPD loaded at all time points, and eight of
the nine items loaded more strongly on the general factor rather than
the specific factors supporting the use of the total score as a valid
measure of outcome for clinical trials of interventions or for pro-
spective longitudinal data. There are two specific factors that may be
clinically useful for investigation as predictors of outcome in future
studies.
The results of this study do not at first appear to support other
previous factor analysis studies. However, this is the first time a bi‐
factor model has been tested in a population of BPD participants.
Previous hierarchical factor studies of the ZAN‐BPD (James & Tay-
lor, 2008; Lai et al., 2012; Speranza et al., 2012; Zanarini, 2003;
Zanarini et al., 2015) or other measures of BPD psychopathology
(Blais et al., 1997; Clarkin et al., 1993; Sanislow, Grilo, & McGla-
shan, 2000) have found two to four factor solutions. These differ-
ences might relate to differences in the populations studied, or to
different methods of statistical analysis. Moreover, these factors are
often correlated with each other (Conway et al., 2012). Studies using
other statistical approaches such as latent class, latent trait or item
response theory often find a single unitary category of BPD.
(Clifton & Pilkonis, 2007; Conway et al., 2012; Feske et al., 2007;
Fossati et al., 1999; Smits et al., 2017; Trull et al., 2011). Our current
findings are therefore consistent with there being a single unitary
general category of BPD symptoms.
Furthermore we confirm and extend a previous study by the
designers of the measure over two time points in a United States
adult clinical sample of BPD patients (Zanarini et al., 2015) by
showing independently in a British clinical sample that the factor
structure and item response of the ZAN‐BPD is generally stable over
four time points. ZAN‐BPD was already shown to have good inter‐
and intra‐rater reliabilities (Zanarini, 2003; Zanarini et al., 2015),
while previous RCTs suggest that the measure is sensitive to change
in BPD patients (Black et al., 2014). For rating scales to be used as a
primary outcome in RCTs, medicine regulatory bodies require inde-
pendent assessment to address the extent to which a rating scale
measures what it is supposed to measure, inter‐ and intra‐rater
reliability and responsiveness for detecting changes in the severity
of disease (EMA, 1998). This study provides additional independent
evidence of what ZAN‐BPD conceptually measures. Therefore, ZAN‐
BPD is a good outcome measure for RCTs with longitudinal designs
because it meets regulatory requirements.
The two factors that we found in addition to the general factor
are of potential clinical significance and might provide additional in-
formation to investigators as predictors of outcome. They should not
be used as outcome measures because eight of the nine ZAN‐BPD
items load more strongly on the general factor than the specific
factors. Chronic anger or frequent angry acts and other impulsivity,
can be viewed as externalising distress, and these items are nega-
tively scored on Factor 1. Chronic emptiness, stress related paranoia
or dissociation and serious identity disturbance, are all forms of
internalised distress that are positively scored on Factor 1. Person-
ality dysfunction including BPD may be considered in terms of
externalising or outward directed distress such as impulsive behav-
iour and internalised distress such as affective and cognitive symp-
toms (Eaton et al., 2011; Lai et al., 2012; Whewell et al., 2000). Factor
2 contrasts patients with BPD who rarely carry out suicidal acts and
display a lot of anxiety and stress‐related symptoms while others
show chronic emptiness and carry out frequent suicidal acts (Whe-
well et al., 2000). Chronic emptiness and self‐destructive acts,
thought to be clinically associated with increased risk of suicide at-
tempts as well as self‐harm (Blasco‐Fontecilla et al., 2013; Klon-
sky, 2008; Miller et al., 2020), were negatively scored on Factor 2.
Frantic efforts to avoid abandonment, stormy relationships, and
stress related paranoia or dissociation have been related to non‐
suicidal self‐injury (Brickman et al., 2014) and are positively
weighted on Factor 2. Affective instability is a core symptom of BPD
so reassuringly it loaded strongly on the general factor (American
Psychiatric Association, 2013). However, it did not load significantly
on Factor 1 or Factor 2 because it may take externalising or inter-
nalising forms and is a feature of both anxiety and stress‐related
symptoms or suicidal acts and emptiness. Factor 1 may be worth
consideration as a predictor of outcome in studies concerned with
expression of BPD distress while Factor 2 is worth further explora-
tion in studies with BPD patients exploring suicidality and non‐
suicidal self‐injury. However, further independent research is
needed to test both factors 1 and 2, including whether these items
are stable traits over time or more state dependent dimensions
of BPD.
T A B L E 3 Model fitting information
for measurement equivalence or
invariance across time (n = 273)
Variance model χ2 (df), p = RMSEA CFI NNFI Δχ2 (df), p = ΔCFI
Configural a 653.026 (480),0.000 0.036 0.946 0.930
Configural ba 597.008 (476),0.000 0.031 0.963 0.950 0.017
Threshold a 1312.844 (638),0.000 0.062 0.791 0.794 695.272 (162),0.000 0.155
Threshold bb 765.887 (613),0.000 0.030 0.953 0.951 194.808 (137),0.001 0.010
aCorrelate item_7 measured at each time but not between baseline and 52 weeks.
bFree 25 (17%) out of 144 item threshold estimates.
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Strengths of this study included a well‐characterised multicentre
clinical sample diagnosed using a standardised psychiatric interview
and DSM‐V criteria for BPD. The participants were from a RCT with
high rates of follow up over four time points across 52 weeks. We
explored longitudinal change using ZAN‐BPD, a measure designed to
assess outcome with sensitivity to change in RCTs. We employed the
latest factor analytical approach ESEM to explore the dimensionality
of ZAN‐BPD and its conceptual stability across four time points over
52 weeks.
The limitations of this study include a smaller sample size at
baseline compared to some other cross‐sectional ZAN‐BPD factor
analysis studies for example, Clifton and Pilkonis (2007), Leung and
Leung (2009), Sanislow, Morey, et al. (2002). However, the sample
size is larger than some other previous factor analysis studies for
example, Becker, Añez, et al. (2010), Speranza et al. (2012), Zanarini
et al. (2015), and has more follow up time points and data than
previous studies. The sample size calculation was based on assessing
treatment effects on the ZAN‐BPD as a primary outcome measure in
the RCT rather than the factor structure of the ZAN‐BPD over time.
Hence the sample size might not be sufficient to test every parameter
in the targeting models (see Supplementary Appendix C). Other
models might show improved fit to the data with larger sample sizes
so further independent replication of these results would be
welcome.
A concern is that bifactor modelling may overfit the data
compared to higher order models, especially if there is over‐reliance
on goodness of fit indices and insufficient attention to their inter-
pretability (Hyland et al., 2020). Further ancillary analyses have been
proposed to evaluate dimensionality (e.g., presenting epidemiological
cut‐off values, internal versus external cross‐validation, and average
relative parameter bias) and reliability of the models (Omega, Omega
Hierarchical, Omega Hierarchical Subscale, and PRV) to statistically
assess whether the bi‐2 factor model or a higher order factor is the
most appropriate model (Rodriguez et al., 2016a, 2016b). However,
these model evaluating indices were not suitable to evaluate the
bifactor model in our study because our model items were ordinal
and the two group factors were correlated. Importantly the bi‐2
factor model showed a more stable item structure over multiple
time points than the 3‐factor model, and was clinically interpretable.
However, reliance on expert clinical interpretation to validate the
specific factors is a limitation without additional concurrently applied
validated measures.
Another limitation is that the sample consisted of those who
agreed to take part in an RCT involving treatment with lamotrigine
and a placebo (Crawford et al., 2018). However, the inclusion criteria
were broad in this pragmatic trial and one of the main uses of the
ZAN‐BPD is as an outcome measure in clinical trials. The majority of
participants were white British adults and all were in contact with
mental health services so the results may not generalise to adoles-
cents, community samples, non‐clinical samples or people with a
different ethnic and cultural background.
In summary, in adult BPD patients ZAN‐BPD measure has a
bi‐2 factor structure with a general factor to which all nine scale
items contribute and two factors that may contribute additional
information on externalising or internalising distress, or depres-
sion and self‐destruction versus interpersonal anxiety and con-
flict. Its dimensional structure is conceptually stable across time.
Therefore, ZAN‐BPD is a conceptually valid scale to measure
total BPD severity that is suitable for longitudinal and inter-
vention studies. The two sub‐factors may be utilised as pre-
dictors of outcome but are not outcome measures in their own
right.
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